To shed light on these questions, Sam West, a postdoctoral researcher at the University of Oxford and his co-authors reviewed randomized trials and observational studies on more than 6,000 adults who were overweight or obese and took GLP-1s or older weight-loss medications compared with 3,000 others in behavioural weight management programs
Coverage often depends on meeting BMI criteria and receiving prior authorization
Common gastrointestinal side effects include nausea, vomiting, diarrhoea, constipation, and abdominal pain, which may overlap with Crohn's symptoms
89 As above-mentioned, T2DM is a major risk factor that affects both organs via engaging different mechanisms such as hypertension, oxidative stress or insulin resistance
It is provided to support investigative work where consistent material specifications and handling are required